Suppr超能文献

探讨中医与肠道微生物群在糖尿病疗效中的相关性。

Review of the correlation between Chinese medicine and intestinal microbiota on the efficacy of diabetes mellitus.

机构信息

Hunan Key Laboratory of The Research and Development of Novel Pharmaceutical Preparation, Changsha Medical University, Changsha, China.

Department of Biochemistry and Molecular Biology, School of Basic Medicine, Changsha Medical University, Changsha, China.

出版信息

Front Endocrinol (Lausanne). 2023 Jan 25;13:1085092. doi: 10.3389/fendo.2022.1085092. eCollection 2022.

Abstract

Diabetes mellitus is a serious metabolic disorder that can lead to a number of life-threatening complications. Studies have shown that intestinal microbiota is closely related to the development of diabetes, making it a potential target for the treatment of diabetes. In recent years, research on the active ingredients of traditional Chinese medicine (TCM), TCM compounds, and prepared Chinese medicines to regulate intestinal microbiota and improve the symptoms of diabetes mellitus is very extensive. We focus on the research progress of TCM active ingredients, herbal compounds, and prepared Chinese medicines in the treatment of diabetes mellitus in this paper. When diabetes occurs, changes in the abundance and function of the intestinal microbiota disrupt the intestinal environment by disrupting the intestinal barrier and fermentation. TCM and its components can increase the abundance of beneficial bacteria while decreasing the abundance of harmful bacteria, regulate the concentration of microbial metabolites, improve insulin sensitivity, regulate lipid metabolism and blood glucose, and reduce inflammation. TCM can be converted into active substances with pharmacological effects by intestinal microbiota, and these active substances can reverse intestinal microecological disorders and improve diabetes symptoms. This can be used as a reference for diabetes prevention and treatment.

摘要

糖尿病是一种严重的代谢紊乱疾病,可导致许多危及生命的并发症。研究表明,肠道微生物群与糖尿病的发生密切相关,使其成为糖尿病治疗的潜在靶点。近年来,研究中药(TCM)活性成分、TCM 化合物和中药复方调节肠道微生物群和改善糖尿病症状的研究非常广泛。我们专注于 TCM 活性成分、草药化合物和中药复方在治疗糖尿病方面的研究进展。当糖尿病发生时,肠道微生物群的丰度和功能的变化通过破坏肠道屏障和发酵来破坏肠道环境。TCM 及其成分可以通过增加有益菌的丰度和减少有害菌的丰度来调节微生物代谢产物的浓度,提高胰岛素敏感性,调节脂质代谢和血糖,减轻炎症。TCM 可以被肠道微生物群转化为具有药理作用的活性物质,这些活性物质可以逆转肠道微生态失调,改善糖尿病症状。这可以作为预防和治疗糖尿病的参考。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bae3/9905712/8280b30b7732/fendo-13-1085092-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验